396 related articles for article (PubMed ID: 26152368)
1. Rate of disease progression: a prognostic biomarker in ALS.
Labra J; Menon P; Byth K; Morrison S; Vucic S
J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):628-32. PubMed ID: 26152368
[TBL] [Abstract][Full Text] [Related]
2. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
3. Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study.
Kjældgaard AL; Pilely K; Olsen KS; Jessen AH; Lauritsen AØ; Pedersen SW; Svenstrup K; Karlsborg M; Thagesen H; Blaabjerg M; Theódórsdóttir Á; Elmo EG; Møller AT; Bonefeld L; Berg M; Garred P; Møller K
BMC Neurol; 2021 Apr; 21(1):164. PubMed ID: 33865343
[TBL] [Abstract][Full Text] [Related]
4. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].
Zhang JH; Wang HF; Yang F; He ZQ; Feng F; Li M; Bai JM; Wang HR; Huang XS
Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):222-227. PubMed ID: 35042292
[No Abstract] [Full Text] [Related]
6. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
[TBL] [Abstract][Full Text] [Related]
7. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
[TBL] [Abstract][Full Text] [Related]
8. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.
Hamidou B; Marin B; Lautrette G; Nicol M; Camu W; Corcia P; Arnes-Bes MC; Tranchant C; Clavelou P; Hannequin D; Maurice G; Beauvais K; Antoine JC; Danel-Brunaud V; Viader F; Preux PM; Couratier P
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):519-527. PubMed ID: 28762856
[TBL] [Abstract][Full Text] [Related]
9. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
[TBL] [Abstract][Full Text] [Related]
10. The predictors of survival in Chinese amyotrophic lateral sclerosis patients.
Wei Q; Chen X; Zheng Z; Guo X; Huang R; Cao B; Zeng Y; Shang H
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):237-44. PubMed ID: 25581512
[TBL] [Abstract][Full Text] [Related]
11. Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis.
Hannaford A; Byth K; Pavey N; Henderson RD; Mathers S; Needham M; Schultz D; Menon P; Kiernan MC; Vucic S
Muscle Nerve; 2023 Jan; 67(1):17-24. PubMed ID: 36214183
[TBL] [Abstract][Full Text] [Related]
12. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
[TBL] [Abstract][Full Text] [Related]
14. Association between depression and survival in Chinese amyotrophic lateral sclerosis patients.
Wei Q; Zheng Z; Guo X; Ou R; Chen X; Huang R; Yang J; Shang H
Neurol Sci; 2016 Apr; 37(4):557-63. PubMed ID: 26758858
[TBL] [Abstract][Full Text] [Related]
15. Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.
Lunetta C; Lizio A; Melazzini MG; Maestri E; Sansone VA
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):93-100. PubMed ID: 26470943
[TBL] [Abstract][Full Text] [Related]
16. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
Czaplinski A; Yen AA; Simpson EP; Appel SH
Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
[TBL] [Abstract][Full Text] [Related]
17. Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post-onset ΔFS for study design and medical practice.
Ludolph AC; Corcia P; Desnuelle C; Heiman-Patterson T; Mora JS; Mansfield CD; Couratier P
Muscle Nerve; 2024 Jul; 70(1):36-41. PubMed ID: 38712849
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.
Watanabe H; Atsuta N; Nakamura R; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Izumi Y; Morita M; Tomiyama H; Taniguchi A; Aiba I; Abe K; Mizoguchi K; Oda M; Kano O; Okamoto K; Kuwabara S; Hasegawa K; Imai T; Aoki M; Tsuji S; Nakano I; Kaji R; Sobue G
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):230-6. PubMed ID: 25548957
[TBL] [Abstract][Full Text] [Related]
19. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
[TBL] [Abstract][Full Text] [Related]
20. Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.
Thouvenot E; Demattei C; Lehmann S; Maceski-Maleska A; Hirtz C; Juntas-Morales R; Pageot N; Esselin F; Alphandéry S; Vincent T; Camu W
Eur J Neurol; 2020 Feb; 27(2):251-257. PubMed ID: 31437330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
